Doxycycline Hyclate Tablet, Delayed Release
Product Images NDC 0591-4575
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Doxycycline Hyclate (NDC 0591-4575). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Doxycycline Hyclate Delayed Release Tablets A09013 2
This is a description of a medication named Doxycycline Hyclate, in the form of delayed-release tablets of 50 mg, with a special coating equivalent to 60 mg. The usual dosage advice is available on the package. It's important to keep it and all drugs out of children's reach and store at the temperature mentioned. Dispense in a tightly closed and light-resistant container. The medication is manufactured by Tova Pharmaceuticals USA. The rest of the text suggests pricing and identification for inventory management purposes.*
Doxycycline Hyclate Delayed Release Tablets A09013 3
This is a description of Doxycycline Hyclate Delayed-Release Tablets, USP containing 200mg of doxycycline per tablet. Each tablet has specially coated pellets equivalent to 200mg of doxycycline. The tablets come in a 60 tablet bottle, and it is not recommended to chew or crush the tablets. The full prescribing information can be found in the package literature. The drug should be stored at a temperature between 15°C and 30°C and kept out of reach of children. The manufacturer is Tova Pharmaceuticals USA, Inc. The lot number is 52-0399, with an expiration date printed on the package.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.